Yarrow Bioscience (YARW) Share-based Compensation (2017 - 2026)
Yarrow Bioscience's Share-based Compensation came in at $436,000 for Q2 2026, down 17.6% from $529,000 a year earlier and down 8.0% from the prior quarter.
Powered by 
Analysis
Yarrow Bioscience (YARW) Share-based Compensation (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Yarrow Bioscience reported Share-based Compensation of $2.2 million, down 19.2% year-over-year; for FY2025, it was $2.31 million, down 30.1% from FY2024.
- Share-based Compensation has declined in each of the last five years, with a five-year compound annual growth rate of -33.8% (FY2020 to FY2025).
- Going back by year, Share-based Compensation was $3.3 million in FY2024 (-0.1%), $3.31 million in FY2023 (-23.1%), $4.3 million in FY2022 (-46.8%) and $8.08 million in FY2021 (-55.4%).
- The Q2 2026 figure represents the lowest quarterly Share-based Compensation since Q2 2017.
- The fastest year-over-year change in Share-based Compensation over five years came in Q1 2024 (growth of 15.1%), and the weakest in Q1 2022 (a decline of 63.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Yarrow Bioscience | 20.59 Mn | -95.92 Mn | - | 436,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 436,000.00 |
| Mar 31, 2026 | 474,000.00 |
| Jun 30, 2025 | 529,000.00 |
| Mar 31, 2025 | 763,000.00 |
| Dec 31, 2024 | 699,000.00 |
| Sep 30, 2024 | 734,000.00 |
| Jun 30, 2024 | 885,000.00 |
| Mar 31, 2024 | 985,000.00 |
| Dec 31, 2023 | 710,000.00 |
| Sep 30, 2023 | 863,000.00 |
| Jun 30, 2023 | 876,000.00 |
| Mar 31, 2023 | 856,000.00 |
| Dec 31, 2022 | 1.07 Mn |
| Sep 30, 2022 | 1.17 Mn |
| Jun 30, 2022 | 1.16 Mn |
| Mar 31, 2022 | 893,000.00 |
| Dec 31, 2021 | 1.33 Mn |
| Sep 30, 2021 | 2.41 Mn |
| Jun 30, 2021 | 1.90 Mn |
| Mar 31, 2021 | 2.44 Mn |
API Access
Yarrow Bioscience Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=YARW&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "YARW", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=YARW&period=max&api_key=YOUR_API_KEY");
const data = await res.json();